Category IV indications for therapeutic apheresis: ASFA fourth special issue
Department of Medicine, Division of Transfusion Medicine
*Blood Component Removal; Disease; Humans; Practice Guidelines as Topic; Societies, Medical; United States
Hemic and Immune Systems | Other Medical Specialties
The American Society for Apheresis (ASFA) Committee on Clinical Applications systematically and critically reviews published information on the use of therapeutic apheresis in clinical practice. On the basis of this review, selected diseases are assigned one of five categories (category I, II, III, IV, and P). The diseases, which were classified as category IV indications, and the rationale for such assignment are reviewed in this article. The diseases assigned to category I, II, III, and newly created category P are discussed in a separate article in this issue.
DOI of Published Version
J Clin Apher. 2007 Jun;22(3):176-80. Link to article on publisher's site
Journal of clinical apheresis
Shaz, Beth H.; Linenberger, Michael L.; Bandarenko, Nicholas; Winters, Jeffrey L.; Kim, Haewon C.; Marques, Marisa B.; Sarode, Ravindra; Schwartz, Joseph; Weinstein, Robert; Wirk, Ashka; and Szczepiorkowski, Zbigniew M., "Category IV indications for therapeutic apheresis: ASFA fourth special issue" (2007). Transfusion Medicine Publications and Presentations. 5.